BPLTTC: Using Antihypertensive agents as risk modifiers for prevention of CV events irrespective of baseline criteria: Scope of Amlodipine Dr. Prem Aggarwal13 Oct 2020 6:47 AM GMTHypertension, a prominent cause of premature mortality, affects ~1.13 billion people worldwide, though blood pressure (BP) control rates remain dismal ...
Effective BP control: High dose ARB monotherapy or combination therapy of ARB and CCB for hypertension? Dr. Prem Aggarwal10 Oct 2020 5:00 AM GMTHypertension (HTN) is a global health hazard and a leading cause of mortality and morbidity. It is ranked third as a cause for disability-adjusted...
Acid suppressants in Cardiac Patients: Sneak Peak of Clinical Guidelines Dr. Prem Aggarwal25 Sep 2020 5:32 AM GMTCardiovascular diseases (CVD) encompass a range of congenital or acquired pathological conditions that affect the structure or function of the heart,...
Trimetazidine in ATPCI Trial: Reading beyond the results Dr Tiny Nair21 Sep 2020 6:30 AM GMTOptimal management in post- Percutaneous Coronary Intervention (PCI) patients with medical therapy is one of the most important goals for any...
Effects of Azelnidipine versus Amlodipine on LV Mass and Longitudinal Function in Hypertensive Patients with LVH Dr. Prem Aggarwal19 Sep 2020 5:30 AM GMTLeft ventricular hypertrophy (LVH) is the structural remodelling of the heart which is a serious consequence of systemic hypertension. It is a...
Prompt BP Control with an Early Combination Therapy: Role of a Fixed-Dose Combination of an ARB and a CCB Dr Tiny Nair11 Sep 2020 5:18 AM GMTEarly start of a combination therapy provides prompt blood pressure control and is recommended by international guidelines as well. Renin-angiotensin s...
Amlodipine and its Efficiency in Cardioprotection: Review Dr. Prem Aggarwal7 Sep 2020 7:15 AM GMTCardiovascular diseases (CVD) are the leading causes of death worldwide (1). As per Lancet's Global Burden of Disease Study 1990–2016 in India,...
Impact of Azelnidipine treatment on left ventricular diastolic performance in patients with BP and mild diastolic dysfunction: CALVLOC trial Dr. Prem Aggarwal28 Aug 2020 7:00 AM GMTOne of the most common forms of heart failure is Left Ventricular Diastolic Dysfunction. Patients with hypertension are at particular risk of heart...
Amlodipine and Cardiovascular outcomes in Hypertensive patients: What Meta-analysis says Dr. Prem Aggarwal17 Aug 2020 7:00 AM GMTA major risk factor for cardiovascular disease is hypertension. A multitude of drugs, including calcium channel blockers (CCBs), β-blockers,...
Role of Vitamin K in reducing Risk of Coronary Heart Disease: The Rotterdam Study. Dr. Kamal Kant Kohli12 Aug 2020 7:00 AM GMTVitamin K is a fat-soluble vitamin which is essential in the human body for the purpose of blood coagulation as well as regulation of calcium...
Controlling Variability in Home Blood Pressure: Which Combination therapy is better? Dr. Prem Aggarwal11 Aug 2020 7:23 AM GMTHypertension is one of the most preventable causes of death worldwide that accounts for more than 12.8% of all deaths annually. Elevated blood...
Impact of Combination Therapy on Arterial Stiffness and Cardiac Function in hypertensive patients: Lessons from AORTA II Trial Dr. Prem Aggarwal28 July 2020 7:00 AM GMTManagement of Blood pressure (BP) in patients is a highly individualized affair. When adequate blood pressure control is not be obtained by...
